Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, Zheng H, Fisseha N, Kalluri HV, Rendenbach-Mueller B, Budur K, Gold M.
Florian H, et al. Among authors: guo q.
Brain. 2023 Jun 1;146(6):2275-2284. doi: 10.1093/brain/awad024.
Brain. 2023.
PMID: 36730056
Free PMC article.
Clinical Trial.